Showing results (781-790 of 1,286) with videos related to
Sort By:
Pageof 129
Liver International : Official Journal of the International Association for the Study of the Liver|January 25, 2023
Extra-hepatic morbidity and mortality in alcohol-related liver disease: Systematic review and meta-analysisMark D Theodoreson, Guruprasad P Aithal, Michael Allison, et al.Trials|October 8, 2011
Recruiting South Asians to a lifestyle intervention trial: experiences and lessons from PODOSA (Prevention of Diabetes & Obesity in South Asians)Anne Douglas, Raj S Bhopal, Ruby Bhopal, et al.Cell Metabolism|December 24, 2019
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight LossAhmad Al-Mrabeh, Sviatlana V Zhyzhneuskaya, Carl Peters, et al.Circulation|August 21, 2023
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE TrialJames L Januzzi, Reza Mohebi, Yuxi Liu, et al.Heart (British Cardiac Society)|August 20, 2018
Potential spironolactone effects on collagen metabolism biomarkers in patients with uncontrolled blood pressureJoão Pedro Ferreira, Patrick Rossignol, Anne Pizard, et al.BMJ (Clinical Research Ed.)|June 26, 2024
Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based studyNathalie Conrad, Geert Molenberghs, Geert Verbeke, et al.European Journal of Heart Failure|December 1, 2023
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trialsJoão Pedro Ferreira, Javed Butler, Stefan D Anker, et al.The Lancet. Healthy Longevity|September 21, 2023
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional, nationwide studyMariam Elmegaard Malik, Jawad Haider Butt, Jarl Emanuel Strange, et al.Journal of the American College of Cardiology|May 7, 2025
Effect of Empagliflozin on the Mechanisms Driving Erythropoiesis and Iron Mobilization in Patients With Heart Failure: The EMPEROR ProgramJoão Pedro Ferreira, Stefan D Anker, Javed Butler, et al.Neurology|November 1, 2013
Total cerebral blood flow and mortality in old age: a 12-year follow-up studyBehnam Sabayan, Jeroen van der Grond, Rudi G Westendorp, et al.Pageof 129